- Alcohol withdrawal syndrome (AWS) occurs when a person who has been drinking heavily reduces or stops alcohol consumption
- It ranges from mild discomfort (anxiety, tremors) to life-threatening emergencies (seizures, delirium tremens)
- Symptoms begin 6-12 hours after the last drink and can peak in severity at 48-72 hours
- Delirium tremens (DTs) occurs in approximately 5% of people undergoing alcohol withdrawal and has a mortality rate of 1-4% with treatment
- The CIWA-Ar scale is the standard tool for assessing withdrawal severity and guiding treatment decisions
- Medical detox using benzodiazepine protocols is the evidence-based standard for managing moderate to severe alcohol withdrawal
Understanding Alcohol Withdrawal
Alcohol withdrawal occurs because chronic alcohol consumption fundamentally alters brain chemistry. Alcohol enhances the inhibitory neurotransmitter GABA and suppresses the excitatory neurotransmitter glutamate. With prolonged heavy drinking, the brain compensates by downregulating GABA receptors and upregulating glutamate receptors to maintain neurochemical balance.
When alcohol is suddenly removed, this compensatory state is exposed — the brain is left in a hyperexcitable state with too little inhibition and too much excitation. The resulting neurochemical storm produces the spectrum of withdrawal symptoms.
Risk Factors for Severe Withdrawal
- Previous episodes of alcohol withdrawal (kindling effect — each withdrawal becomes more severe)
- History of withdrawal seizures or delirium tremens
- Duration and amount of alcohol use (higher = greater risk)
- Concurrent use of other sedatives (benzodiazepines, barbiturates)
- Older age and poor physical health
- Co-occurring medical conditions (liver disease, infections, electrolyte imbalances)
Withdrawal Timeline and Symptoms
Stage 1 — Minor Withdrawal (6-12 hours): Anxiety, insomnia, nausea, abdominal discomfort, tremors (especially hand tremors), sweating, elevated heart rate, headache, and irritability. These symptoms are uncomfortable but not dangerous.
Stage 2 — Moderate Withdrawal (12-48 hours): Escalating tremors, confusion, agitation, elevated blood pressure and temperature, diaphoresis (profuse sweating), and alcoholic hallucinosis — visual, auditory, or tactile hallucinations while the person remains aware that they are hallucinating (distinguishing this from delirium).
Stage 3 — Withdrawal Seizures (24-48 hours): Tonic-clonic (grand mal) seizures occur in approximately 5-10% of people undergoing withdrawal. They may occur without prior warning symptoms and can cluster (multiple seizures in succession). Status epilepticus (prolonged seizure) is a medical emergency.
Stage 4 — Delirium Tremens (48-72 hours, can appear up to day 5): The most severe form of withdrawal. Characterized by global confusion, severe agitation, vivid hallucinations (often visual — classically described as seeing insects or small animals), autonomic instability (dangerously high heart rate, blood pressure, and temperature), and profound diaphoresis. DTs is a medical emergency with mortality up to 37% if untreated. With proper ICU management, mortality decreases to 1-4%.
Medical Management
Assessment: The CIWA-Ar (Clinical Institute Withdrawal Assessment for Alcohol, Revised) is a 10-item scale that standardizes withdrawal severity assessment. Scores guide treatment intensity: mild (under 10), moderate (10-18), and severe (over 18).
Benzodiazepine Protocol: The standard of care. Long-acting benzodiazepines (chlordiazepoxide, diazepam) provide smooth symptom control, while shorter-acting options (lorazepam) are preferred for patients with liver disease. Two approaches exist — symptom-triggered dosing (medication given based on CIWA scores) and fixed-schedule dosing with additional doses as needed.
Thiamine and Nutritional Support: IV thiamine (vitamin B1) before glucose administration to prevent Wernicke-Korsakoff syndrome. Magnesium, folate, and multivitamin supplementation. IV fluids for dehydration.
Monitoring: Continuous vital signs, serial CIWA assessments, seizure precautions, and observation for DTs. Patients with severe withdrawal may require ICU-level monitoring.
Adjunctive Medications: Anticonvulsants (carbamazepine, valproate) may supplement benzodiazepines. Beta-blockers and clonidine can help manage autonomic symptoms. Antipsychotics (haloperidol) for severe agitation or hallucinations — used cautiously as they can lower seizure threshold.
After Detox
Detox is stabilization, not treatment. Without follow-up addiction treatment, relapse rates exceed 80%. Transition to comprehensive treatment (behavioral therapy, medication management, support groups, and structured programs) is essential for sustained recovery.
FAQ
When should I go to the ER for alcohol withdrawal?
Seek emergency care if you experience seizures or tremors that worsen, confusion or disorientation, hallucinations, chest pain or difficulty breathing, fever above 101°F (38.3°C), inability to keep fluids down due to vomiting, or any symptoms that feel dangerous or out of control. When in doubt, err on the side of caution — alcohol withdrawal is one of the few withdrawal syndromes that can kill.
Can I manage mild alcohol withdrawal at home?
Mild withdrawal (anxiety, mild tremors, insomnia) may be manageable at home with medical guidance — your doctor can prescribe short-term medications and monitor you via phone or telehealth. However, predicting withdrawal severity is difficult. Anyone with a history of seizures or DTs, heavy/prolonged drinking, or significant medical conditions should undergo supervised detox. If symptoms worsen at home, go to the ER immediately.
What is the kindling effect?
Kindling refers to the observation that each successive episode of alcohol withdrawal tends to be more severe than the last. This occurs because repeated withdrawal-induced neural hyperexcitability causes lasting changes in brain excitability. A person who has had two mild withdrawal episodes may experience seizures during a third withdrawal. This progressive severity is one reason why early and definitive treatment is important — the longer addiction continues, the more dangerous withdrawal becomes.
References:
- Mirijello, A. et al. (2015). Identification and Management of Alcohol Withdrawal Syndrome. Drugs.
- American Society of Addiction Medicine. (2023). Clinical Practice Guideline on Alcohol Withdrawal Management.
- Bayard, M. et al. (2004). Alcohol Withdrawal Syndrome. American Family Physician.
- Sullivan, J.T. et al. (1989). CIWA-Ar Scale Validation. British Journal of Addiction.
Valley Spring Recovery Center Editorial Team
This article was reviewed by the Valley Spring Recovery Center editorial team, comprising licensed therapists, medical professionals, and addiction specialists dedicated to providing accurate, evidence-based information about substance use disorders and treatment options.